From:  Analysis of SDC2 and SEPT9 promoters methylation in plasma cfDNA to detect colorectal and precancerous lesions

 Clinicopathologic characteristics of patients with positive cfDNA plasma test results by methylation status of SDC2 and SEPT9 markers

VariableAllCombined test positive (n = 78)No. of mSDC2 positive (n = 69)No. of mSEPT9 positive (n = 30)
Age (years)
    ≤ 4910819 (24.4%)18 (26.1%)9 (30.0%)
    50–596020 (25.6%)16 (23.2%)7 (23.3%)
    60–696025 (32.1%)23 (33.3%)7 (23.3%)
    ≥ 702514 (17.9%)12 (17.4%)7 (23.3%)
Gender
    Male8328 (35.9%)25 (36.2%)13 (43.3%)
    Female17050 (64.1%)44 (63.8%)17 (56.7%)
Location
    Proximal colon7033 (47.1%)28 (45.2%)18 (66.7%)
    Distal colon6837 (52.9%)34 (54.8%)9 (33.3%)
CRC stage
    I + II8886
    III + IV101096
Histological classification
    Advanced adenoma141195
    Serrated lesions1710104
    Non-advanced adenoma5719174
    Hyperplastic polyps19853